Core Viewpoint - The company, Akeso Inc. (09939), announced a share placement agreement involving the sale of 20.673 million shares at a price of HKD 2.08 per share, representing approximately 4.62% of the company's issued share capital as of the announcement date [1] Group 1 - The seller, KT International Investment Limited, agrees to sell 20.673 million shares, and the placement agent will use its best efforts to facilitate the purchase by buyers at the specified price [1] - The placement price of HKD 2.08 represents a discount of approximately 18.75% compared to the closing price of HKD 2.56 on July 31, 2025 [1] - The estimated net proceeds from the placement are approximately HKD 40.34 million, which will be used for general working capital and business purposes [1] Group 2 - The placement agent has conditionally agreed to act on behalf of the seller to place the shares, which will represent about 4.42% of the company's issued share capital after the placement, assuming no changes in the issued share capital until completion [1] - The company has conditionally agreed to issue 20.673 million new shares at the subscription price, which is the same as the placement price [1]
开拓药业-B(09939)拟折让约18.75%先旧后新配售2067.3万股 净筹约4034万港元